Early Prevention of Obesity: Tackling from Conception

By Melike Belenli Gümüş

October 16, 2024

A recent article discusses the potential for monitoring obesity from the earliest stages of development, including during the fetal period in the womb. This proactive approach highlights the importance of addressing obesity right from conception in order to achieve early prevention of obesity.

Early Prevention of Obesity

The article highlights research focused on the early prevention of obesity through a project named “eprObes” (Early Prevention of Obesity). This initiative aims to implement interventions that could significantly lower the risk of obesity later in life.

Factors Influencing Obesity

The study aims to identify and understand the various factors that contribute to obesity, starting from the pre-conception period and continuing through pregnancy and early childhood. These factors include genetic, environmental, and lifestyle influences that can affect the development of obesity in children.

Importance of Prenatal Care

The research emphasises the critical role of prenatal care in monitoring both the mother’s and the fetus’s health. Preventive measures during pregnancy could be key in reducing the incidence of obesity later in life.

Long-Term Health Implications

By addressing obesity at its earliest roots, the study aims to lower the risk of long-term health complications associated with obesity, such as metabolic syndrome, diabetes, and other related health issues.

Overall, the article indicates a shift towards a more proactive and preventive approach to managing obesity, starting at the earliest possible stage of human development. This new focus could lead to healthier outcomes for future generations.

Reference url

Recent Posts

Global AIDS Update 2024
     

Global AIDS Update 2024: Progress and Challenges

📊 The **2024 Global AIDS Update** from UNAIDS reveals critical insights on the ongoing HIV epidemic, progress made, and the challenges that lie ahead.

With nearly 40 million people living with HIV worldwide, it’s clear that while we are progressing, much work remains to ensure equitable access to treatment and services. Learn more about the current trends, treatment coverage, and the urgent need for a sustainable response that respects health and human rights.

#SyenzaNews #HIVAIDS #GlobalHealth

obesity early prevention
       

Early Prevention of Obesity: Tackling from Conception

🔍 Discover groundbreaking insights on obesity prevention from the womb! The insight discusses the importance of monitoring and intervening early to combat obesity through the eprObes project. This proactive approach emphasises the critical role of prenatal care and aims to improve health outcomes for future generations.

Read more to find out how addressing obesity from conception can change lives!

#SyenzaNews #ObesityPrevention #PrenatalCare

inavolisib breast cancer treatment
        

FDA Approves Inavolisib Breast Cancer Treatment

🌟 Big news in breast cancer treatment! The FDA has approved inavolisib (Itovebi) in combination with palbociclib (Ibrance) and fulvestrant (Faslodex) for adults with endocrine-resistant, PIK3CA-mutated, HR-positive, HER2-negative breast cancer. This innovative therapy offers new hope for patients who have faced recurrence after prior endocrine therapy.

Learn more about the significant trial outcomes and the role of the FoundationOne Liquid CDx companion diagnostic!

#SyenzaNews #BreastCancer #FDAApproval

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

JOIN NEWSLETTER




SERVICES

© 2024 Syenza™. All rights reserved.